Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
Propofol pretreatment attenuates lipopolysaccharide-induced acute lung injury in rats by activating the phosphoinositide-3-kinase/Akt pathway
|
Autores: |
Zhao,L.L.
Hu,G.C.
Zhu,S.S.
Li,J.F.
Liu,G.J.
|
Data: |
2014-12-01
|
Ano: |
2014
|
Palavras-chave: |
Acute lung injury
Propofol
Lipopolysaccharide
PI3K/Akt pathway
|
Resumo: |
The aim of this study was to investigate the effect of propofol pretreatment on lipopolysaccharide (LPS)-induced acute lung injury (ALI) and the role of the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) pathway in this procedure. Survival was determined 48 h after LPS injection. At 1 h after LPS challenge, the lung wet- to dry-weight ratio was examined, and concentrations of protein, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in bronchoalveolar lavage fluid (BALF) were determined using the bicinchoninic acid method or ELISA. Lung injury was assayed via lung histological examination. PI3K and p-Akt expression levels in the lung tissue were determined by Western blotting. Propofol pretreatment prolonged survival, decreased the concentrations of protein, TNF-α, and IL-6 in BALF, attenuated ALI, and increased PI3K and p-Akt expression in the lung tissue of LPS-challenged rats, whereas treatment with wortmannin, a PI3K/Akt pathway specific inhibitor, blunted this effect. Our study indicates that propofol pretreatment attenuated LPS-induced ALI, partly by activation of the PI3K/Akt pathway.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014001201062
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/1414-431X20143949
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.47 n.12 2014
|
Direitos: |
info:eu-repo/semantics/openAccess
|